Work

Venous thromboembolism in lung transplant recipients: timing and clinical impact, a 10-year cohort analysis

Year: 2025

Type: article

Abstract: Introduction The burden of venous thromboembolism (VTE) in lung transplant (LTx) recipients is not fully elucidated despite its frequent occurrence. We report the incidence of VTE and characteristics of VTE in a large LTx cohort, assess severity using risk stratification algorithms, and explore associations with graft survival and chronic lung allograft dysfunction (CLAD). Methods A retrospective cohort analysis was performed on LTx recipients transplanted between July 2012 and August 2022 in our center. Primary outcome was incidence of VTE. Three groups were compared: patients with early VTE ( i.e. within the first six months after LTx), late VTE ( i.e. beyond the first six months after LTx) and no VTE. Results 94/286 patients (33%) were diagnosed with VTE (median follow-up of 4.3 years): 67/94 (71%) early VTE and 27/94 (29%) late VTE. 66/94 (70%) of VTE events were pulmonary embolism (PE). In the early VTE group none of the PE cases were classified as intermediate-high risk PE and one patient had high risk (fatal) PE. Graft survival was not different between groups; median CLAD-free survival was shorter in patients with late VTE (6.2 years) compared to patients without VTE during follow-up (9.8 years) (p = 0.044). Conclusions 33% of LTx recipients developed VTE, 71% within the first six months after LTx. 70% of cases were acute PE, but fatal or severe non-fatal PE were rare. No effect of VTE on graft survival was seen; CLAD-free survival was shorter in patients with late VTE compared to patients without VTE.

Source: JHLT Open

DOI: 10.1016/j.jhlto.2025.100458